Regimbeau has been ranked among the top French firms in pharmaceutical patents, according to a recent study undertaken by Patent-Pilot. A great performance for Regimbeau, especially since most of the patent applications in question are drafted by our teams, as part of the daily support of our direct clients, whom we thank for their trust.
On the same topic
JUVE Patent – 2026 Rankings
A leading reference in the European patent market, JUVE Patent has published its 2026 rankings, highlighting firms and practitioners recognized for their expertise in patent matters across Europe. This year again, Regimbeau is among the recommended firms in...
ByRegimbeau recognized among Europe's leading patent law firms by the Financial Times in 2026
We are proud to announce that Regimbeau once again features in the Europe's Leading Patent Law Firms 2026 ranking published by the Financial Times. Conducted in partnership with the independent...
IP STARS 2026: Regimbeau and its experts recognized once again
Regimbeau is pleased to be featured once again in the Managing IP IP STARS 2026 rankings, one of the leading international references for intellectual property firms. Four of our professionals have received individual recognition this year: Patent Stars 2026 Rising Stars 2026 Regimbeau has also retained its Tier 1 ranking in Patent Prosecution and remains recommended in Trademark Prosecution – Patent & Trademark Attorney Firms 2026. These recognitions highlight the dedication of our teams and the confidence our clients continue to place in us. ...
By